The University of Chicago Header Logo

Connection

Jessica J. Kandel to Topotecan

This is a "connection" page, showing publications Jessica J. Kandel has written about Topotecan.
Connection Strength

0.540
  1. Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis. Mol Cancer Res. 2004 Jan; 2(1):36-42.
    View in: PubMed
    Score: 0.229
  2. Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor. J Pediatr Surg. 2001 Dec; 36(12):1781-4.
    View in: PubMed
    Score: 0.198
  3. Topotecan is anti-angiogenic in experimental hepatoblastoma. J Pediatr Surg. 2002 Jun; 37(6):857-61.
    View in: PubMed
    Score: 0.051
  4. Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor. J Pediatr Surg. 2001 Aug; 36(8):1177-81.
    View in: PubMed
    Score: 0.048
  5. Distinct response of experimental neuroblastoma to combination antiangiogenic strategies. J Pediatr Surg. 2002 Mar; 37(3):518-22.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.